Key Details
Annual ROE
-211.20%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 10, 2022Recent annual earnings:
Mar 31, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
May 22, 2023Analyst ratings
Recent major analysts updates
13 May '20 Maxim Group
Buy26 Nov '19 Raymond James
Market Perform25 Nov '19 Maxim Group
Hold23 July '19 B. Riley Securities
Neutral23 July '19 B. Riley FBR
Neutral16 July '19 B. Riley Securities
Sell16 July '19 B. Riley
Sell12 Nov '18 B. Riley Securities
Neutral12 Nov '18 B. Riley FBR
Neutral14 May '18 Maxim Group
BuyScreeners with ADMP included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Adamis Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Adamis Pharmaceuticals Corporation (ADMP) Q1 2023 Earnings Call Transcript
ADMP
Seeking Alpha15 May 2023
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP ) Q1 2023 Earnings Conference Call May 15, 2023 5:00 PM ET Company Participants Robert Uhl - MD, ICR Westwicke David Marguglio - CEO David Benedicto - CFO Eboo Versi - CEO, DMK Pharmaceuticals Conference Call Participants Operator Greetings, and welcome to Adamis Pharmaceuticals First Quarter 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
FAQ
- What is the primary business of Adamis Pharmaceuticals?
- What is the ticker symbol for Adamis Pharmaceuticals?
- Does Adamis Pharmaceuticals pay dividends?
- What sector is Adamis Pharmaceuticals in?
- What industry is Adamis Pharmaceuticals in?
- What country is Adamis Pharmaceuticals based in?
- When did Adamis Pharmaceuticals go public?
- Is Adamis Pharmaceuticals in the S&P 500?
- Is Adamis Pharmaceuticals in the NASDAQ 100?
- Is Adamis Pharmaceuticals in the Dow Jones?
- When was Adamis Pharmaceuticals's last earnings report?
- When does Adamis Pharmaceuticals report earnings?
- Should I buy Adamis Pharmaceuticals stock now?
What is the primary business of Adamis Pharmaceuticals?
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.
What is the ticker symbol for Adamis Pharmaceuticals?
The ticker symbol for Adamis Pharmaceuticals is NASDAQ:ADMP
Does Adamis Pharmaceuticals pay dividends?
No, Adamis Pharmaceuticals does not pay dividends
What sector is Adamis Pharmaceuticals in?
Adamis Pharmaceuticals is in the Healthcare sector
What industry is Adamis Pharmaceuticals in?
Adamis Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry
What country is Adamis Pharmaceuticals based in?
Adamis Pharmaceuticals is headquartered in United States
When did Adamis Pharmaceuticals go public?
Adamis Pharmaceuticals's initial public offering (IPO) was on 14 August 1995
Is Adamis Pharmaceuticals in the S&P 500?
No, Adamis Pharmaceuticals is not included in the S&P 500 index
Is Adamis Pharmaceuticals in the NASDAQ 100?
No, Adamis Pharmaceuticals is not included in the NASDAQ 100 index
Is Adamis Pharmaceuticals in the Dow Jones?
No, Adamis Pharmaceuticals is not included in the Dow Jones index
When was Adamis Pharmaceuticals's last earnings report?
Adamis Pharmaceuticals's most recent earnings report was on 10 August 2022
When does Adamis Pharmaceuticals report earnings?
The date for Adamis Pharmaceuticals's next earnings report has not been announced yet
Should I buy Adamis Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions